Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Breast 1

Conditions

Prostatic Neoplasms 9Neuroendocrine Tumors 3Gastro-enteropancreatic neuroendocrine tumor 2Urogenital Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Diseases 1Prostate Cancer Metastatic 1Pheochromocytoma 1Paraganglioma 1Oligometastatic Prostate Cancer (OMPC) 1Neoplasm Metastasis 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-Resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Lung Neoplasms 1Digestive System Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma 1Breast Neoplasms 1Biochemically Recurrent Prostate Carcinoma 1Advanced Gastroenteropancreatic Neuroendocrine Tumor 1

Interventions

Fulvestrant 125Trastuzumab 115Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Anastrozole 72Capecitabine 71Cyclophosphamide 69Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 61trastuzumab deruxtecan 58Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 48Magnetic Resonance Spectroscopy 48Docetaxel 48Blood Specimen Collection 40olaparib 39Standard of Care 37Biopsy 34sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Exercise 29Doxorubicin 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Lutetium-177 × 1 year × Clear all
NCT07274852 2026-01-06

A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 1 Recruiting
22 enrolled
BreastHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡